Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, Merck & Co. 16.286.
GSK vs Merck & Co. Net Worth and Market Cap
GSK (GSK) and Merck & Co. (MRK) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $16.3B for Merck & Co.. Merck & Co. leads on revenue.
GSK's gross margin is 73.0% versus 81.9% for Merck & Co.. GSK's net margin is 5.2% versus -26.0% for Merck & Co..
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, Merck & Co..| Metric | GSK | Merck & Co. |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $16.29B |
| Cost of Revenue | $2.85B | $2.94B |
| Gross Profit | $7.74B | $13.34B |
| Operating Income | $606.00M | $-1.88B |
| Net Income | $548.00M | $-4.24B |
| R&D Expense | $4.37B | $12.56B |
| Earnings Per Share | $0.28 | -$1.72 |
| Gross Margin | 73.0% | 81.9% |
| Operating Margin | 5.7% | -11.6% |
| Net Profit Margin | 5.2% | -26.0% |
| Free Cash Flow | $2.78B | $2.93B |
| Cumulative Free Cash Flow | $157.21B | $245.22B |
| Operating Cash Flow | $3.19B | $3.92B |
| Cash & Equivalents | $3.89B | $5.33B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.